Please login to the form below

Not currently logged in
Email:
Password:

BI

This page shows the latest BI news and features for those working in and with pharma, biotech and healthcare.

Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data

Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data

The trial also met its secondary endpoint, demonstrating that BI 1015550 showed acceptable safety and tolerability in IPF patients after 12 weeks. ... Boehringer Ingelheim will begin a phase 3 clinical trial programme to continue investigating if BI

Latest news

More from news
Approximately 4 fully matching, plus 98 partially matching documents found.

Latest Intelligence

  • The ‘Million Hour Challenge’ The ‘Million Hour Challenge’

    Since the initiative launched, AstraZeneca has seen two consecutive increases in the bi-annual employee engagement survey, with 69% of AstraZeneca employees agreeing that ‘Together, we are making progress in our

  • Is it time we stopped talking about adherence? Is it time we stopped talking about adherence?

    attractive and valuable bi-product.

  • Deal Watch September 2016 Deal Watch September 2016

    Boehringer Ingelheim granted Amgen worldwide rights to BI 836909, a bispecific T cell engager designed to treat multiple myeloma. ... Under the agreement, Daiichi Sankyo will acquire a licence to Zymeworks' platforms to develop a bi-specific antibody

  • The human perspective The human perspective

    But you can deal with the other three factors. This is where Boehringer has a key strength because there is a very, very strong culture, which is built on our BI

  • Deal Watch April 2016 Deal Watch April 2016

    1, 200. ZymeWorks (US). GSK (UK). License and option. Preclinical bi-specific antibodies based on Azymetric platform for treatment of solid tumours.

More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 13 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....